These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27186074)

  • 1. Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.
    Markey KA; Uldall M; Botfield H; Cato LD; Miah MA; Hassan-Smith G; Jensen RH; Gonzalez AM; Sinclair AJ
    J Pain Res; 2016; 9():223-32. PubMed ID: 27186074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?
    Sinclair AJ; Walker EA; Burdon MA; van Beek AP; Kema IP; Hughes BA; Murray PI; Nightingale PG; Stewart PM; Rauz S; Tomlinson JW
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5348-56. PubMed ID: 20826586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and recognition of idiopathic intracranial hypertension: A narrative review.
    Zhou C; Zhou Y; Liu L; Jiang H; Wei H; Zhou C; Ji X
    CNS Neurosci Ther; 2024 Aug; 30(8):e14895. PubMed ID: 39097911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
    Markey KA; Ottridge R; Mitchell JL; Rick C; Woolley R; Ives N; Nightingale P; Sinclair AJ
    JMIR Res Protoc; 2017 Sep; 6(9):e181. PubMed ID: 28923789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the pathogenesis of IIH: an inflammatory perspective.
    Sinclair AJ; Ball AK; Burdon MA; Clarke CE; Stewart PM; Curnow SJ; Rauz S
    J Neuroimmunol; 2008 Sep; 201-202():212-20. PubMed ID: 18676028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis?
    Ooi LY; Walker BR; Bodkin PA; Whittle IR
    Br J Neurosurg; 2008 Apr; 22(2):187-94. PubMed ID: 18348012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial.
    Markey K; Mitchell J; Botfield H; Ottridge RS; Matthews T; Krishnan A; Woolley R; Westgate C; Yiangou A; Alimajstorovic Z; Shah P; Rick C; Ives N; Taylor AE; Gilligan LC; Jenkinson C; Arlt W; Scotton W; Fairclough RJ; Singhal R; Stewart PM; Tomlinson JW; Lavery GG; Mollan SP; Sinclair AJ
    Brain Commun; 2020; 2(1):fcz050. PubMed ID: 32954315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
    Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review.
    Mollan SP; Grech O; Sinclair AJ
    Headache; 2021 Jun; 61(6):808-816. PubMed ID: 34106464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic intracranial hypertension; research progress and emerging themes.
    Batra R; Sinclair A
    J Neurol; 2014 Mar; 261(3):451-60. PubMed ID: 24085346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative observational study on the clinical presentation, intracranial volume measurements, and intracranial pressure scores in patients with either Chiari malformation Type I or idiopathic intracranial hypertension.
    Frič R; Eide PK
    J Neurosurg; 2017 Apr; 126(4):1312-1322. PubMed ID: 27341045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema.
    Bridges KJ; Raslan AM
    World Neurosurg; 2018 Mar; 111():e221-e227. PubMed ID: 29258930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension.
    Pérez MA; Bialer OY; Bruce BB; Newman NJ; Biousse V
    J Neuroophthalmol; 2013 Dec; 33(4):330-7. PubMed ID: 24042170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).
    Kalyvas A; Neromyliotis E; Koutsarnakis C; Komaitis S; Drosos E; Skandalakis GP; Pantazi M; Gobin YP; Stranjalis G; Patsalides A
    Neurosurg Rev; 2021 Apr; 44(2):773-792. PubMed ID: 32335853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension.
    Samancı B; Samancı Y; Tüzün E; Altıokka-Uzun G; Ekizoğlu E; İçöz S; Şahin E; Küçükali Cİ; Baykan B
    Cephalalgia; 2017 May; 37(6):525-531. PubMed ID: 27193133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of idiopathic intracranial hypertension in parturients: anesthetic considerations.
    Karmaniolou I; Petropoulos G; Theodoraki K
    Can J Anaesth; 2011 Jul; 58(7):650. PubMed ID: 21519980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
    Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
    J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Pituitary Morphology and Function Are Preserved in Female Patients With Idiopathic Intracranial Hypertension Under Pharmacological Treatment.
    Tozzi R; Moramarco A; Watanabe M; Balena A; Caputi A; Gangitano E; Petrangeli E; Mariani S; Gnessi L; Lubrano C
    Front Endocrinol (Lausanne); 2020; 11():613054. PubMed ID: 33488525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic intracranial hypertension in the Middle East: A growing concern.
    Almarzouqi SJ; Morgan ML; Lee AG
    Saudi J Ophthalmol; 2015; 29(1):26-31. PubMed ID: 25859136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.